David Turkaly
Stock Analyst at Citizens
(2.20)
# 2,800
Out of 5,182 analysts
153
Total ratings
39.72%
Success rate
-3.85%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXG MiMedx Group | Maintains: Market Outperform | $7 → $6 | $3.61 | +66.20% | 3 | Apr 30, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Outperform | $120 → $105 | $82.67 | +27.01% | 15 | Apr 29, 2026 | |
| AXGN Axogen | Maintains: Market Outperform | $42 → $50 | $42.63 | +17.29% | 10 | Apr 29, 2026 | |
| TELA TELA Bio | Maintains: Market Outperform | $5 → $3 | $1.09 | +175.23% | 8 | Mar 27, 2026 | |
| LNTH Lantheus Holdings | Maintains: Market Outperform | $78 → $85 | $87.78 | -3.17% | 11 | Feb 27, 2026 | |
| SYK Stryker | Upgrades: Market Outperform | $440 | $290.88 | +51.27% | 4 | Dec 19, 2025 | |
| APYX Apyx Medical | Upgrades: Market Outperform | $8 | $2.85 | +180.70% | 6 | Nov 12, 2025 | |
| KIDS OrthoPediatrics | Maintains: Market Outperform | $35 → $25 | $15.78 | +58.43% | 12 | Oct 10, 2025 | |
| OFIX Orthofix Medical | Reiterates: Market Perform | n/a | $12.00 | - | 2 | Jun 6, 2025 | |
| GMED Globus Medical | Reiterates: Market Perform | n/a | $90.60 | - | 3 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $100 | $55.32 | +80.77% | 12 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $265 → $280 | $212.25 | +31.92% | 18 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $35 → $25 | $10.65 | +134.74% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $62 → $55 | $23.34 | +135.65% | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $400 → $500 | $469.24 | +6.56% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $119.89 | - | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $13.35 | +139.70% | 7 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $16 | $6.17 | +159.32% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $7 → $3 | $2.02 | +48.51% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $10.11 | -50.54% | 1 | Oct 6, 2017 |
MiMedx Group
Apr 30, 2026
Maintains: Market Outperform
Price Target: $7 → $6
Current: $3.61
Upside: +66.20%
Zimmer Biomet Holdings
Apr 29, 2026
Maintains: Market Outperform
Price Target: $120 → $105
Current: $82.67
Upside: +27.01%
Axogen
Apr 29, 2026
Maintains: Market Outperform
Price Target: $42 → $50
Current: $42.63
Upside: +17.29%
TELA Bio
Mar 27, 2026
Maintains: Market Outperform
Price Target: $5 → $3
Current: $1.09
Upside: +175.23%
Lantheus Holdings
Feb 27, 2026
Maintains: Market Outperform
Price Target: $78 → $85
Current: $87.78
Upside: -3.17%
Stryker
Dec 19, 2025
Upgrades: Market Outperform
Price Target: $440
Current: $290.88
Upside: +51.27%
Apyx Medical
Nov 12, 2025
Upgrades: Market Outperform
Price Target: $8
Current: $2.85
Upside: +180.70%
OrthoPediatrics
Oct 10, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $15.78
Upside: +58.43%
Orthofix Medical
Jun 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $12.00
Upside: -
Globus Medical
May 27, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $90.60
Upside: -
May 20, 2025
Reiterates: Market Outperform
Price Target: $100
Current: $55.32
Upside: +80.77%
May 16, 2025
Maintains: Market Outperform
Price Target: $265 → $280
Current: $212.25
Upside: +31.92%
May 9, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $10.65
Upside: +134.74%
May 9, 2025
Maintains: Market Outperform
Price Target: $62 → $55
Current: $23.34
Upside: +135.65%
May 5, 2025
Maintains: Market Outperform
Price Target: $400 → $500
Current: $469.24
Upside: +6.56%
Apr 2, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $119.89
Upside: -
Feb 25, 2025
Reiterates: Market Outperform
Price Target: $32
Current: $13.35
Upside: +139.70%
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $6.17
Upside: +159.32%
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $2.02
Upside: +48.51%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $10.11
Upside: -50.54%